Romosozumab versus Alendronate and Fracture Risk in Women with           Osteoporosis

Research output: Contribution to journal › Letter

1 Citation (Scopus)

Original language	English
Pages (from-to)	194-195
Number of pages	2
Journal	The New England Journal of Medicine
Volume	378
Issue number	2
DOIs	https://doi.org/10.1056/NEJMc1714810
Publication status	Published - 11 Jan 2018

Cite this

@article{dbccddcf5c3940a2a95007b7908ff8fa,

title = "Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis",

author = "Lewis, {Joshua R.} and Schousboe, {John T.} and Prince, {Richard L.}",

year = "2018",

month = "1",

day = "11",

doi = "10.1056/NEJMc1714810",

language = "English",

volume = "378",

pages = "194--195",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOC",

number = "2",

}

TY - JOUR

T1 - Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis

AU - Lewis, Joshua R.

AU - Schousboe, John T.

AU - Prince, Richard L.

PY - 2018/1/11

Y1 - 2018/1/11

UR - http://www.scopus.com/inward/record.url?scp=85044933623&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1714810

DO - 10.1056/NEJMc1714810

M3 - Letter

C2 - 29322752

AN - SCOPUS:85044933623

VL - 378

SP - 194

EP - 195

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

SN - 0028-4793

IS - 2

ER -